Hypoxia Increases Placenta Growth Factor Expression in Human Myocardium and Cultured Neonatal Rat Cardiomyocytes

Journal of Heart and Lung Transplantation

Volumn 28, Issue 2, 2009, Pages 183-190

  Torry, Ronald J ^a   Tomanek, Robert J ^b   Zheng, Wei ^b   Miller, Steven J ^c   Labarrere, Carlos A ^d   Torry, Donald S ^e  

^a DRAKE UNIVERSITY   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d METHODIST RESEARCH INSTITUTE   (United States)

^e SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; FIBRIN; MESSENGER RNA; PLACENTAL GROWTH FACTOR; TROPONIN I; VASCULOTROPIN RECEPTOR 1;

ANGIOGENESIS; ARTICLE; CELL CULTURE; CELL INFILTRATION; ENDOCARDIAL BIOPSY; EXTRACELLULAR MATRIX; FIBRIN DEPOSITION; HEART MUSCLE; HEART MUSCLE BIOPSY; HEART MUSCLE CELL; HEART TRANSPLANTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; MICROVASCULATURE; OXIDATIVE STRESS; PATHOLOGY; PLACENTA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANIMALS, NEWBORN; ANOXIA; BIOPSY; CELL HYPOXIA; CELLS, CULTURED; DNA PRIMERS; HEART; HEART TRANSPLANTATION; HUMANS; MYOCYTES, CARDIAC; NEOVASCULARIZATION, PATHOLOGIC; PREGNANCY PROTEINS; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 59549084297     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2008.11.917     Document Type: Article

References (45)

1. Perez-Castellano N., Garcia E.J., Abeytua M., et al. Influence of collateral circulation on in-hospital death from anterior acute myocardial infarction. J Am Coll Cardiol 31 (1998) 512-518
2. Tammela T., Enholm B., Alitalo K., et al. The biology of vascular endothelial growth factors. Cardiovasc Res 65 (2005) 550-563
3. Persico M.G., Vincenti V., and DiPalma T. Structure, expression and receptor-binding properties of placenta growth factor (PlGF). Curr Top Microbiol Immunol 237 (1999) 31-40
4. Iwama H., Uemura S., Naya N., et al. Cardiac expression of placental growth factor predicts the improvement of chronic phase left ventricular function in patients with acute myocardial infarction. J Am Coll Cardiol 47 (2006) 1559-1567
5. Heeschen C., Dimmeler S., Fichtlscherer S., et al. Prognostic value of placental growth factor in patients with acute chest pain. JAMA 291 (2004) 435-441
6. Lenderink T., Heeschen C., Fichtlscherer S., et al. Elevated placental growth factor levels are associated with adverse outcomes at four-year follow-up in patients with acute coronary syndromes. J Am Coll Cardiol 47 (2006) 307-311
7. Apple F.S., Pearce L.A., Chung A., et al. Multiple biomarker use for detection of adverse events in patients presenting with symptoms suggestive of acute coronary syndrome. Clin Chem 53 (2007) 874-881
8. Khaliq A., Foreman D., Ahmed A., et al. Increased expression of placenta growth factor in proliferative diabetic retinopathy. Lab Invest 78 (1998) 109-116
9. Carmeliet P., Moons L., Luttun A., et al. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med 7 (2001) 575-583
10. Failla C.M., Odorisio T., Cianfarani F., et al. Placenta growth factor is induced in human keratinocytes during wound healing. J Invest Dermatol 115 (2000) 388-395
11. Maes C., Coenegrachts L., Stockmans I., et al. Placental growth factor mediates mesenchymal cell development, cartilage turnover, and bone remodeling during fracture repair. J Clin Invest 116 (2006) 1230-1242
12. Nomura M., Yamagishi S., Harada S., et al. Placenta growth factor (PlGF) mRNA expression in brain tumors. J Neurooncol 40 (1998) 123-130
13. Migdal M., Huppertz B., Tessler S., et al. Neuropilin-1 is a placenta growth factor-2 receptor. J Biol Chem 273 (1998) 22272-22278
14. Autiero M., Waltenberger J., Communi D., et al. Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1. Nat Med 9 (2003) 936-943
15. Shore V.H., Wang T.H., Wang C.L., et al. Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast. Placenta 18 (1997) 657-665
16. Loboda A., Jazwa A., Jozkowicz A., et al. Angiogenic transcriptome of human microvascular endothelial cells: effect of hypoxia, modulation by atorvastatin. Vasc Pharmacol 187 (2006) 26-30
17. Green C.J., Lichtlen P., Huynh N.T., et al. Placenta growth factor gene expression is induced by hypoxia in fibroblasts: a central role for metal transcription factor-1. Cancer Res 61 (2001) 2696-2703
18. Kelly B.D., Hackett S.F., Hirota K., et al. Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1. Circ Res 93 (2003) 1074-1081
19. Seko Y., Takahashi N., Shibuya M., et al. Pulsatile stretch stimulates vascular endothelial growth factor (VEGF) secretion by cultured rat cardiac myocytes. Biochem Biophys Res Commun 254 (1999) 462-465
20. Zheng W., Seftor E.A., Meininger C.J., et al. Mechanisms of coronary angiogenesis in response to stretch: role of VEGF and TGF-beta. Am J Physiol Heart Circ Physiol 280 (2001) H909-H917
21. Zheng W., Brown M.D., Brock T.A., et al. Bradycardia-induced coronary angiogenesis is dependent on vascular endothelial growth factor. Circ Res 85 (1999) 192-198
22. Li J., Hampton T., Morgan J.P., et al. Stretch-induced VEGF expression in the heart. J Clin Invest 100 (1997) 18-24
23. Tomanek R.J., and Schatteman G.C. Angiogenesis: new insights and therapeutic potential. Anat Rec 261 (2000) 126-135
24. Labarrere C.A., Nelson D.R., Cox C.J., et al. Cardiac-specific troponin I levels and risk of coronary artery disease and graft failure following heart transplantation. JAMA 284 (2000) 457-464
25. Torry R.J., Labarrere C.A., Torry D.S., et al. Vascular endothelial growth factor expression in transplanted human hearts. Transplantation 60 (1995) 1451-1457
26. Stewart S., Winters G.L., Fishbein M.C., et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 24 (2005) 1710-1720
27. Labarrere C.A., Nelson D.R., and Faulk W.P. Myocardial fibrin deposits in the first month after transplantation predict subsequent coronary artery disease and graft failure in cardiac allograft recipients. Am J Med 105 (1998) 207-213
28. Labarrere C.A., Torry R.J., Nelson D.R., et al. Vascular antithrombin and clinical outcome in heart transplant patients. Am J Cardiol 87 (2001) 425-431
29. Torry R.J., Bai L., Miller S.J., et al. Increased vascular endothelial growth factor expression in human hearts with microvascular fibrin. J Mol Cell Cardiol 33 (2001) 175-184
30. Shibuya M., Yamaguchi S., Yamane A., et al. Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family. Oncogene 5 (1990) 519-524
31. Terman B.I., Carrion M.E., Kovacs E., et al. Identification of a new endothelial cell growth factor receptor tyrosine kinase. Oncogene 6 (1991) 1677-1683
32. Latil A., Bieche I., Pesche S., et al. VEGF overexpression in clinically localized prostate tumors and neuropilin-1 overexpression in metastatic forms. Int J Cancer 89 (2000) 167-171
33. Lin T.N., Wang C.K., Cheung W.M., et al. Induction of angiopoietin and Tie receptor mRNA expression after cerebral ischemia-reperfusion. J Cereb Blood Flow Metab 20 (2000) 387-395
34. Coulet F., Nadaud S., Agrapart M., et al. Identification of hypoxia-response element in the human endothelial nitric-oxide synthase gene promoter. J Biol Chem 278 (2003) 46230-46240
35. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucl Acids Res 29 (2001) 2002-2007
36. Gigante B., Tarsitano M., Cimini V., et al. Placenta growth factor is not required for exercise-induced angiogenesis. Angiogenesis 7 (2004) 277-284
37. Briguori C., Testa U., Colombo A., et al. Relation of various plasma growth factor levels in patients with stable angina pectoris and total occlusion of a coronary artery to the degree of coronary collaterals. Am J Cardiol 97 (2006) 472-476
38. Giordano F.J., Gerber H.P., Williams S.P., et al. A cardiac myocyte vascular endothelial growth factor paracrine pathway is required to maintain cardiac function. Proc Natl Acad Sci USA 98 (2001) 5780-5785
39. Cao Y.H., Linden P., Shima D., et al. In vivo angiogenic activity and hypoxia induction of heterodimers of placenta growth factor vascular endothelial growth factor. J Clin Invest 98 (1996) 2507-2511
40. Kurz K., Voelker R., Zdunek D., et al. Effect of stress-induced reversible ischemia on serum concentrations of ischemia-modified albumin, natriuretic peptides and placental growth factor. Clin Res Cardiol 96 (2007) 152-159
41. 2 tension. Am J Physiol 271 (1996) C1172-C1180
42. Cramer M., Nagy I., Murphy B.J., et al. NF-kappaB contributes to transcription of placenta growth factor and interacts with metal responsive transcription factor-1 in hypoxic human cells. Biol Chem 386 (2005) 865-872
43. Rottbauer W., Just S., Wessels G., et al. VEGF-PLCgamma1 pathway controls cardiac contractility in the embryonic heart. Genes Dev 19 (2005) 1624-1634
44. Desai J., Holt-Shore V., Torry R.J., et al. Signal transduction and biological function of placenta growth factor in primary human trophoblast. Biol Reprod 60 (1999) 887-892
45. Autiero M., Luttun A., Tjwa M., et al. Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders. J Thromb Haemost 1 (2003) 1356-1370